KLF17 and colorectal carcinoma: In the TCGA cohort, KLF3 (hazard ratio [HR], 0.501; 95% confidence interval [CI], 0.272–0.920; P=0.025), KLF14 (HR, 1.454; 95% CI, 1.059–1.995; P=0.020), and KLF17 (HR, 1.241; 95% CI, 1.030–1.494, P=0.023) were identified as potential biomarkers in the univariate analysis, but after Cox proportional hazards analysis, only KLF3 (HR, 0.473; 95% CI, 0.230–0.831; P=0.012) was shown to be independently predictive of overall survival in patients with CRC.